{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:57:04Z","timestamp":1793138224029,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1001\/jamapsychiatry.2018.3079","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T16:39:59Z","timestamp":1552495199000},"page":"374","source":"Crossref","is-referenced-by-count":113,"title":["Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials"],"prefix":"10.1001","volume":"76","author":[{"given":"Daniel E.","family":"Falk","sequence":"first","affiliation":[{"name":"National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"O\u2019Malley","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Witkiewitz","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of New Mexico, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Anton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raye Z.","family":"Litten","sequence":"additional","affiliation":[{"name":"National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Slater","sequence":"additional","affiliation":[{"name":"CSR, Incorporated"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl F.","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Hasin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Mailman School of Public Health, Columbia University, New York, New York"},{"name":"Department of Epidemiology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bankole","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Meulien","sequence":"additional","affiliation":[{"name":"CRD Neurology, Lundbeck SAS, Valby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Ryan","sequence":"additional","affiliation":[{"name":"National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Fertig","sequence":"additional","affiliation":[{"name":"National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alcohol Clinical Trials Initiative (ACTIVE) Workgroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"yoi180078r2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","article-title":"Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"74","author":"Grant","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"yoi180078r3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III.","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1-3","key":"yoi180078r4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.","volume":"99","author":"Mark","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"yoi180078r5","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/acer.13093","article-title":"Discovery, development, and adoption of medications to treat alcohol use disorder: goals for the phases of medications development.","volume":"40","author":"Litten","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"2-3","key":"yoi180078r6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.06.008","article-title":"Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"86","author":"Cohen","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"yoi180078r7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fpsyt.2016.00182","article-title":"Pharmacotherapy for alcohol use disorders: physicians\u2019 perceptions and practices.","volume":"7","author":"Ponce Martinez","year":"2016","journal-title":"Front Psychiatry"},{"key":"yoi180078r8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugalcdep.2016.01.005","article-title":"A 10-year study of factors associated with alcohol treatment use and non-use in a US population sample.","volume":"160","author":"Chartier","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"yoi180078r9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3109\/10826084.2014.891616","article-title":"Alcohol consumption, dependence, and treatment barriers: perceptions among nontreatment seekers with alcohol dependence.","volume":"49","author":"Wallhed Finn","year":"2014","journal-title":"Subst Use Misuse"},{"issue":"2","key":"yoi180078r10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/npp.2011.182","article-title":"The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders.","volume":"37","author":"Anton","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"yoi180078r12","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/acer.2007.31.issue-12","article-title":"Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up.","volume":"31","author":"Dawson","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"yoi180078r13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.15288\/jsad.2010.71.210","article-title":"Transitioning into and out of problem drinking across seven years.","volume":"71","author":"Delucchi","year":"2010","journal-title":"J Stud Alcohol Drugs"},{"issue":"12","key":"yoi180078r14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/acer.2010.34.issue-12","article-title":"Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.","volume":"34","author":"Falk","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"yoi180078r15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/acer.12273","article-title":"Five-year healthcare utilization and costs among lower-risk drinkers following alcohol treatment.","volume":"38","author":"Kline-Simon","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"yoi180078r16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2105\/AJPH.85.6.823","article-title":"Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers.","volume":"85","author":"Sanchez-Craig","year":"1995","journal-title":"Am J Public Health"},{"issue":"1","key":"yoi180078r17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15288\/jsad.2017.78.59","article-title":"How much is too much? patterns of drinking during alcohol treatment and associations with post-treatment outcomes across three alcohol clinical trials.","volume":"78","author":"Witkiewitz","year":"2017","journal-title":"J Stud Alcohol Drugs"},{"issue":"5","key":"yoi180078r18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/acer.13054","article-title":"The relationship between end-of-treatment alcohol use and subsequent healthcare costs: do heavy drinking days predict higher healthcare costs?","volume":"40","author":"Aldridge","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"yoi180078r21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S2215-0366(17)30130-X","article-title":"Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.","volume":"4","author":"Hasin","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"yoi180078r22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/acer.13272","article-title":"Clinical validation of reduced alcohol consumption after treatment for alcohol dependence using the World Health Organization risk drinking levels.","volume":"41","author":"Witkiewitz","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"yoi180078r23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000371547","article-title":"Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patients.","volume":"21","author":"Aubin","year":"2015","journal-title":"Eur Addict Res"},{"issue":"17","key":"yoi180078r24","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"yoi180078r25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.","volume":"7","author":"Litten","year":"2013","journal-title":"J Addict Med"},{"issue":"14","key":"yoi180078r26","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial.","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"yoi180078r29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer.","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"issue":"7168","key":"yoi180078r30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat.","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"issue":"7","key":"yoi180078r31","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/acer.13106","article-title":"Missing data in alcohol clinical trials with binary outcomes.","volume":"40","author":"Hallgren","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"yoi180078r27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption: Psychosocial and Biological Methods","author":"Sobell","year":"1992"},{"key":"yoi180078r28","doi-asserted-by":"crossref","DOI":"10.1037\/e563242012-001","volume-title":"Form 90: A Structured Assessment Interview for Drinking and Related Behaviors: Test Manual","author":"Miller","year":"1996"},{"key":"yoi180078r1","unstructured":"Centers for Disease Control and Prevention (CDC). Alcohol and public health: alcohol-related disease impact application (ARDI): 2013. http:\/\/nccd.cdc.gov\/DPH_ARDI\/default\/default.aspx. Accessed March 7, 2018."},{"key":"yoi180078r11","unstructured":"US Food and Drug Administration. Alcoholism: developing drugs for treatment guidance for industry: draft guidance. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM433618.pdf. Published February 2015. Accessed May 2, 2018."},{"key":"yoi180078r19","unstructured":"World Health Organization. International guide for monitoring alcohol consumption and related harm. http:\/\/www.who.int\/iris\/handle\/10665\/66529. Published 2000. Accessed May 2, 2018."},{"key":"yoi180078r20","unstructured":"European Medicines Agency. Guideline on the development of medicinal products for the treatment of alcohol dependence. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/03\/WC500074898.pdf. Published February 10, 2010. Accessed May 2, 2018."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamapsychiatry\/article-pdf\/76\/4\/374\/17420104\/jamapsychiatry_falk_2019_oi_180078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T18:24:24Z","timestamp":1554315864000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.3079"}},"subtitle":["A Secondary Analysis of 3 Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3079","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}